We are live on
!
Find out more
AstraZeneca
AZN
AZN
397 hedge funds and large institutions have $8.72B invested in AstraZeneca in 2016 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 154 increasing their positions, 98 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
225% more call options, than puts
Call options by funds: $99.3M | Put options by funds: $30.6M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
57% more repeat investments, than reductions
Existing positions increased: 154 | Existing positions reduced: 98
32% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 38
20% more capital invested
Capital invested by funds: $7.26B → $8.72B (+$1.46B)
2% more funds holding
Funds holding: 389 → 397 (+8)
1.23% more ownership
Funds ownership: 10.2% → 11.43% (+1.2%)
Holders
397
Holders Change
+8
Holders Change %
+2.06%
% of All Funds
10.6%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
50
Increased
154
Reduced
98
Closed
38
Calls
$99.3M
Puts
$30.6M
Net Calls
+$68.8M
Net Calls Change
+$55.4M
Top Buyers
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$66.5M |
| 2 |
Jennison Associates
New York
|
-$63.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$37.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22.3M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$18.5M |
